Publication Information

{'id': 'https://openalex.org/W2003243316', 'doi': 'https://doi.org/10.1158/1538-7445.am2013-3421', 'title': 'Abstract 3421: Differential potentiation of temozolomide and camptothecin by the PARP inhibitors olaparib and veliparib in relationship with their PARP-DNA trapping abilities, and lack of impact of PARP inhibitors on cisplatin activity.', 'display_name': 'Abstract 3421: Differential potentiation of temozolomide and camptothecin by the PARP inhibitors olaparib and veliparib in relationship with their PARP-DNA trapping abilities, and lack of impact of PARP inhibitors on cisplatin activity.', 'publication_year': 2013, 'publication_date': '2013-04-01', 'ids': {'openalex': 'https://openalex.org/W2003243316', 'doi': 'https://doi.org/10.1158/1538-7445.am2013-3421', 'mag': '2003243316'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2013-3421', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5042114293', 'display_name': '\ufeffYves Pommier', 'orcid': 'https://orcid.org/0000-0002-3108-0758'}, 'institutions': [{'id': 'https://openalex.org/I4210149717', 'display_name': 'Center for Cancer Research', 'ror': 'https://ror.org/05bjen692', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210140884', 'https://openalex.org/I4210149717']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Yves G. Pommier', 'raw_affiliation_strings': ['NCI-CCR, Bethesda, MD.'], 'affiliations': [{'raw_affiliation_string': 'NCI-CCR, Bethesda, MD.', 'institution_ids': ['https://openalex.org/I4210149717']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5074228660', 'display_name': 'Junko Murai', 'orcid': 'https://orcid.org/0000-0003-2023-6160'}, 'institutions': [{'id': 'https://openalex.org/I4210149717', 'display_name': 'Center for Cancer Research', 'ror': 'https://ror.org/05bjen692', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210140884', 'https://openalex.org/I4210149717']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Junko Murai', 'raw_affiliation_strings': ['NCI-CCR, Bethesda, MD.'], 'affiliations': [{'raw_affiliation_string': 'NCI-CCR, Bethesda, MD.', 'institution_ids': ['https://openalex.org/I4210149717']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 65}, 'biblio': {'volume': '73', 'issue': '8_Supplement', 'first_page': '3421', 'last_page': '3421'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9983, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9983, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10123', 'display_name': 'DNA Repair Mechanisms', 'score': 0.9587, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/veliparib', 'display_name': 'Veliparib', 'score': 0.99139094}, {'id': 'https://openalex.org/keywords/olaparib', 'display_name': 'Olaparib', 'score': 0.98267704}, {'id': 'https://openalex.org/keywords/parp-inhibitor', 'display_name': 'PARP inhibitor', 'score': 0.8568609}, {'id': 'https://openalex.org/keywords/temozolomide', 'display_name': 'Temozolomide', 'score': 0.5981827}, {'id': 'https://openalex.org/keywords/camptothecin', 'display_name': 'Camptothecin', 'score': 0.58063}, {'id': 'https://openalex.org/keywords/du145', 'display_name': 'DU145', 'score': 0.5626147}], 'concepts': [{'id': 'https://openalex.org/C2781312401', 'wikidata': 'https://www.wikidata.org/wiki/Q7919041', 'display_name': 'Veliparib', 'level': 5, 'score': 0.99139094}, {'id': 'https://openalex.org/C2779962180', 'wikidata': 'https://www.wikidata.org/wiki/Q7083106', 'display_name': 'Olaparib', 'level': 5, 'score': 0.98267704}, {'id': 'https://openalex.org/C2779138821', 'wikidata': 'https://www.wikidata.org/wiki/Q7118227', 'display_name': 'PARP inhibitor', 'level': 5, 'score': 0.8568609}, {'id': 'https://openalex.org/C2777389519', 'wikidata': 'https://www.wikidata.org/wiki/Q425088', 'display_name': 'Temozolomide', 'level': 3, 'score': 0.5981827}, {'id': 'https://openalex.org/C2779682216', 'wikidata': 'https://www.wikidata.org/wiki/Q419964', 'display_name': 'Camptothecin', 'level': 2, 'score': 0.58063}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.5667324}, {'id': 'https://openalex.org/C2776438761', 'wikidata': 'https://www.wikidata.org/wiki/Q5206280', 'display_name': 'DU145', 'level': 5, 'score': 0.5626147}, {'id': 'https://openalex.org/C182979987', 'wikidata': 'https://www.wikidata.org/wiki/Q3907241', 'display_name': 'Poly ADP ribose polymerase', 'level': 4, 'score': 0.5070815}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.41086268}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.39759666}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.34217602}, {'id': 'https://openalex.org/C96232424', 'wikidata': 'https://www.wikidata.org/wiki/Q4118072', 'display_name': 'Cancer cell', 'level': 3, 'score': 0.20757264}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.18713775}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.18170083}, {'id': 'https://openalex.org/C82381507', 'wikidata': 'https://www.wikidata.org/wiki/Q416878', 'display_name': 'Polymerase', 'level': 3, 'score': 0.1426956}, {'id': 'https://openalex.org/C552990157', 'wikidata': 'https://www.wikidata.org/wiki/Q7430', 'display_name': 'DNA', 'level': 2, 'score': 0.11153069}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.106064916}, {'id': 'https://openalex.org/C2778227246', 'wikidata': 'https://www.wikidata.org/wiki/Q1365309', 'display_name': 'Glioma', 'level': 2, 'score': 0.089859426}, {'id': 'https://openalex.org/C2779723316', 'wikidata': 'https://www.wikidata.org/wiki/Q6459234', 'display_name': 'LNCaP', 'level': 4, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2013-3421', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.46, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4389134950', 'https://openalex.org/W4387642987', 'https://openalex.org/W4296617455', 'https://openalex.org/W3134914296', 'https://openalex.org/W3009707110', 'https://openalex.org/W2944149590', 'https://openalex.org/W2890903471', 'https://openalex.org/W2118122348', 'https://openalex.org/W2016425953', 'https://openalex.org/W2003243316'], 'abstract_inverted_index': {'Abstract': [0], 'We': [1, 34], 'recently': [2], 'showed': [3], 'that': [4, 17, 37, 106, 186], 'poly(ADP-ribose)': [5], 'polymerase': [6], '(PARP)': [7], 'inhibitors': [8, 39, 87, 306, 323], 'act': [9], 'by': [10, 66, 303], 'a': [11, 137, 194], 'novel': [12], 'allosteric': [13], 'mechanism': [14], 'of': [15, 21, 57, 78, 85, 109, 131, 164, 177, 190, 212, 221, 253, 257, 281, 299, 319, 321, 330, 335], 'action': [16], 'involves': [18], 'the': [19, 76, 82, 89, 94, 125, 129, 162, 175, 188, 206, 210, 251, 271, 286, 304, 331, 336], 'trapping': [20, 80, 202, 220, 256, 315], 'PARP-DNA': [22, 46, 182, 203, 222, 241, 258, 314], 'complexes': [23, 242, 259], 'in': [24, 41, 55, 81, 128, 160, 174, 187, 209, 243, 250, 310], 'addition': [25], 'to': [26, 44, 227, 234, 284], 'their': [27, 42, 58, 313], 'previously': [28], 'established': [29], 'NAD-competitive': [30], 'catalytic': [31, 62, 266, 279], 'inhibitory': [32], 'mechanism).': [33], 'also': [35], 'demonstrated': [36], 'PARP': [38, 63, 68, 79, 86, 265, 282, 305, 322], 'differ': [40], 'ability': [43], 'trap': [45], 'complexes,': [47], 'with': [48, 88, 312], 'olaparib': [49, 71, 115, 153, 168, 192, 215, 225, 255, 307], 'being': [50], 'more': [51, 156, 197, 261], 'effective': [52], 'than': [53, 116, 140, 158, 199, 263], 'veliparib': [54, 141, 159, 170, 200, 217, 309], 'spite': [56], 'comparable': [59, 173], 'potency': [60], 'as': [61], 'inhibitors).': [64], 'Here,': [65], 'using': [67], 'knockout': [69], 'cells,': [70, 103, 152], 'and': [72, 93, 118, 149, 169, 236, 301, 308, 317], 'veliparib,': [73, 117], 'we': [74, 104, 184], 'tested': [75], 'role': [77], 'potentiating': [83, 161], 'effect': [84, 139], 'alkylating': [90], 'agent': [91], 'temozolomide': [92, 110, 165, 300], 'topoisomerase': [95, 274], 'I': [96], 'inhibitor,': [97], 'camptothecin.': [98, 178], 'Using': [99], 'isogenic': [100], 'chicken': [101], 'DT40': [102], 'show': [105], 'PARP-dependent': [107], 'potentiation': [108, 298], 'is': [111, 154, 193, 260, 269], 'markedly': [112, 155], 'greater': [113, 138], 'for': [114, 273, 339], 'goes': [119], 'beyond': [120], 'knocking': [121, 133], 'out': [122, 134], 'PARP-1.': [123], 'On': [124, 205], 'other': [126, 207], 'hand,': [127, 208], 'case': [130, 176, 189, 211, 252, 272], 'camptothecin,': [132, 213], 'PARP-1': [135], 'has': [136], 'or': [142, 231], 'olaparib.': [143], 'In': [144], 'human': [145], 'DU145': [146, 230], 'prostate': [147], 'cancer': [148], 'SF295': [150, 232], 'glioblastoma': [151], 'potent': [157, 198], 'cytotoxicity': [163], 'whereas': [166], 'both': [167], 'are': [171], 'almost': [172], 'By': [179], 'measuring': [180], 'cellular': [181], 'complexes),': [183], 'find': [185], 'temozolomide,': [191, 254], 'least': [195], '10-fold': [196], 'at': [201], 'complexes.': [204, 223], 'neither': [214], 'nor': [216], 'produced': [218], 'detectable': [219, 240], 'Finally,': [224], 'fails': [226], 'sensitize': [228], 'DT40,': [229], 'cells': [233], 'cisplatin': [235, 325], 'does': [237], 'not': [238, 270], 'induce': [239], 'cisplatin-treated': [244], 'cells.': [245], 'These': [246], 'results': [247], 'suggest': [248], 'that,': [249], 'toxic': [262], 'inactivating': [264], 'activity,': [267], 'which': [268], 'I-induced': [275], 'DNA': [276], 'damage,': [277], 'where': [278], 'inactivation': [280], 'appears': [283], 'be': [285], 'sole': [287], 'enhancing': [288], 'mechanism.': [289], 'Citation': [290], 'Format:': [291], 'Yves': [292], 'G.': [293], 'Pommier,': [294], 'Junko': [295], 'Murai.': [296], 'Differential': [297], 'camptothecin': [302], 'relationship': [311], 'abilities,': [316], 'lack': [318], 'impact': [320], 'on': [324], 'activity.': [326], '[abstract].': [327], 'In:': [328], 'Proceedings': [329], '104th': [332], 'Annual': [333], 'Meeting': [334], 'American': [337], 'Association': [338], 'Cancer': [340, 350], 'Research;': [341], '2013': [342], 'Apr': [343], '6-10;': [344], 'Washington,': [345], 'DC.': [346], 'Philadelphia': [347], '(PA):': [348], 'AACR;': [349], 'Res': [351], '2013;73(8': [352], 'Suppl):Abstract': [353], 'nr': [354], '3421.': [355], 'doi:10.1158/1538-7445.AM2013-3421': [356]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2003243316', 'counts_by_year': [], 'updated_date': '2024-12-08T13:04:31.108236', 'created_date': '2016-06-24'}